SAT-495 Stratification of liver fibrosis in individuals at-risk of metabolic dysfunction and alcohol-associated liver disease (MetALD)
Luis Antonio Díaz(Pontificia Universidad Católica de Chile), Rohit S. Loomba(Virginia Commonwealth University), Harris Siddiqi(University of California San Diego), Veeral Ajmera(University of California San Diego), David Martí‐Aguado(INCLIVA Health Research Institute), Amy J. Wagoner Johnson(University of Illinois Urbana-Champaign), Monica A. Tincopa(University of California San Diego), Ricki Bettencourt(University of California San Diego), Ria Loomba(University of California San Diego), Federica Tavaglione(Università Campus Bio-Medico), Maral Amangurbanova(University of California San Diego), L. Richards(University of California San Diego), Egbert Madamba(University of California San Diego), Asma Khan-Riches(University of California San Diego), Claude B. Sirlin(University of California San Diego)
Cited by 1
Related Papers
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
|Hepatology|2018|4.7k
AASLD guidelines for the treatment of hepatocellular carcinoma
|Hepatology|2017|4.2k
Quantitative assessment of liver fat with magnetic resonance imaging and spectroscopy
|Journal of Magnetic Resonance Imaging|2011|677